Ignite Creation Date:
2025-12-25 @ 12:22 AM
Ignite Modification Date:
2026-06-06 @ 9:09 PM
Study NCT ID:
NCT02690558
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-02-10
First Post:
2016-02-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 2 Study of Pembrolizumab in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy
Sponsor:
Organization: